August 2009 followup to the original 2007 Swedish TV news segment on persistent Propecia side effects, confirming permanent erectile dysfunction as a possible outcome from Finasteride use, and the manufacturer's requirements to add this side effect to their labelling in Europe.
----------
*** NEWSFLASH: SIGN UP FOR CANADIAN CLASS ACTION LAWSUIT, OR REGISTER FOR POSSIBLE USA OR INTERNATIONAL PROPECIA & PROSCAR CLASS ACTION / MASS TORT LITIGATION AT [ Ссылка ] ***
*** DEC 2010 - BBC RADIO1 NEWS STORY -- BALDNESS DRUG PROPECIA 'RISKING MEN'S SEXUAL HEALTH'.
- LISTEN TO AUDIO (9:50) @ [ Ссылка ]
- READ FULL NEWS STORY @ [ Ссылка ]
*** OCT 2010 - DOCTOR WARNS AGAINST FINASTERIDE USE IN YOUNG MEN: [ Ссылка ]
*** MARCH 2010 - DOCTOR CONDUCTING STUDY ON PERMANENT PROPECIA SIDE EFFECTS, REQUESTING PARTICIPANTS: [ Ссылка ]
PERMANENT SEXUAL SIDE EFFECTS NOW OFFICIAL IN EUROPE: [ Ссылка ]
DETAILS: [ Ссылка ]
TRANSLATED NEWS STORY: [ Ссылка ]
MERCK'S RESPONSE (Translated): [ Ссылка ]
-----------
PERMANENT ERECTILE DYSFUNCTION NOW OFFICIAL:
December 2008 - Swedish Medical Products agency concludes safety investigation of Propecia and advise that use of Propecia may result in persistent sexual side effects. The Agency's updated safety information lists difficulty in obtaining an erection that persists even after discontinuing Propecia as a possible side effect.
2010 - SWEDISH MEDICAL AGENCY
[ Ссылка ]
* Pg.2: "Long-term data on fertility in humans are lacking, and specific studies in subfertile men have not been conducted. The male patients who were planning to father a child were initially excluded from clinical trials... spontaneous reports of infertility and /or poor seminal quality were received post-marketing."
* Pg.3: "The following have been reported in post-marketing use: persistence of erectile dysfunction after discontinuation of treatment with PROPECIA; male breast cancer"
Since the Swedish Medical Products Agency is the organization within Europe that is assigned to monitor the safety of Propecia, the text in the new Prescription Information is valid for all European countries.
-----------
Many young men around the world based their decision to take Finasteride in the form of Propecia 1mg or Proscar 5mg for hairloss, based on the assurances by their doctor, the FDA's Propecia clinical trials (2% of men may experience side effects) and Merck's medical literature that states any side effects experienced on the medication should resolve with continued use, or most certainly upon discontinuation.
Unfortunately, this has not been the case for a certain percentage of men worldwide. These men continue to suffer (often in silence) from devastating, and thus far irreversible, mental, physical and sexual side effects from Finasteride -- despite Merck's claims that such side effects would resolve after quitting.
Most in the medical community are unaware of this possibility, dismiss such claims, or do not care to investigate further as to how or why the drug can leave some men with complete loss of sex drive, shrunken penis/scrotum, Peyronie's Disease (penile fibrosis), loss of penile sensitivity, loss of spontaneous/morning/nocturnal erections, chronic fatigue, decreased mental acuity, memory recall issues and much more -- or why after quitting those with permanent issues often find their Testosterone, LH & FSH levels drop through the floor (amongst other hormonal imbalances), often to hypogonadal levels typically only seen during male Andropause in old age.
Read the FAQ and Finasteride Studies section of [ Ссылка ] for more information about the dangers and unlisted mechanisms of action of this drug, far beyond what Merck discloses in their advertising, medical literature and in their studies submitted to the FDA for Propecia approval.
5AR and DHT are absolutely critical for the proper mental, physical, sexual and fertility functioning of some men, and there are no guarantess that things will return to normal after taking drugs that disrupt or alter the endocrine system... including those like Finasteride that create a surrogate state of 5AR2 deficiency in men, thereby instilling a hormonal profile that matches that of a 5AR2-deficient pseudohermaphrodite.
End.
